PubRank

Mineo Kurokawa

Author PubWeight™ 201.21‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res 2005 11.02
2 Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays. Am J Hum Genet 2007 4.52
3 Frequent inactivation of A20 in B-cell lymphomas. Nature 2009 4.22
4 AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat Med 2004 4.00
5 Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms. Nature 2009 3.80
6 Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol 2004 2.28
7 Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells. Cell Stem Cell 2008 2.05
8 Nilotinib is associated with a reduced incidence of BCR-ABL mutations vs imatinib in patients with newly diagnosed chronic myeloid leukemia in chronic phase. Blood 2013 2.03
9 Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma. Cancer Sci 2009 1.95
10 Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia. Blood 2009 1.78
11 Prdm3 and Prdm16 are H3K9me1 methyltransferases required for mammalian heterochromatin integrity. Cell 2012 1.78
12 Related transplantation with HLA-1 Ag mismatch in the GVH direction and HLA-8/8 allele-matched unrelated transplantation: a nationwide retrospective study. Blood 2011 1.65
13 NEDD9 promotes oncogenic signaling in mammary tumor development. Cancer Res 2009 1.53
14 HIV-negative, HHV-8-unrelated primary effusion lymphoma-like lymphoma: report of two cases. Am J Hematol 2010 1.46
15 Moxifloxacin is more effective than tosufloxacin in reducing chemotherapy-induced febrile neutropenia in patients with hematological malignancies. Leuk Lymphoma 2013 1.44
16 Differences in blast immunophenotypes among disease types in myelodysplastic syndromes: a multicenter validation study. Leuk Res 2012 1.42
17 Antineoplastic effect of a single oral dose of the novel Flt3 inhibitor KRN383 on xenografted human leukemic cells harboring Flt3-activating mutations. Leuk Res 2006 1.42
18 Post-transplant lymphoproliferative disorder after adult-to-adult living donor liver transplant: case series and review of literature. Leuk Lymphoma 2010 1.41
19 Central nervous system relapse in patients with diffuse large B-cell lymphoma: analysis of incidence and prognostic factors. Leuk Lymphoma 2014 1.39
20 Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins. Blood 2011 1.37
21 Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity. J Exp Med 2011 1.36
22 Highly efficient ex vivo expansion of human hematopoietic stem cells using Delta1-Fc chimeric protein. Stem Cells 2006 1.35
23 Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cells. Blood 2010 1.29
24 Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples. Blood 2012 1.29
25 Differing roles of Akt and serum- and glucocorticoid-regulated kinase in glucose metabolism, DNA synthesis, and oncogenic activity. J Biol Chem 2003 1.25
26 Evaluation of genome-wide power of genetic association studies based on empirical data from the HapMap project. Hum Mol Genet 2007 1.25
27 AML1/Runx1 negatively regulates quiescent hematopoietic stem cells in adult hematopoiesis. J Immunol 2008 1.24
28 Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells. J Clin Invest 2013 1.20
29 Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders. Int J Hematol 2009 1.19
30 The corepressor mSin3A regulates phosphorylation-induced activation, intranuclear location, and stability of AML1. Mol Cell Biol 2004 1.16
31 Derivation of functional mature neutrophils from human embryonic stem cells. Blood 2009 1.15
32 Erdheim-Chester disease: multisystem involvement and management with interferon-alpha. Leuk Res 2009 1.13
33 Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma. Br J Haematol 2008 1.13
34 AML1/Runx1 rescues Notch1-null mutation-induced deficiency of para-aortic splanchnopleural hematopoiesis. Blood 2006 1.13
35 Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity. J Clin Invest 2014 1.11
36 A role for RUNX1 in hematopoiesis and myeloid leukemia. Int J Hematol 2013 1.09
37 Host-residual invariant NK T cells attenuate graft-versus-host immunity. J Immunol 2005 1.08
38 Runx1/AML-1 ranks as a master regulator of adult hematopoiesis. Cell Cycle 2004 1.07
39 Both Notch1 and Notch2 contribute to the regulation of melanocyte homeostasis. Pigment Cell Melanoma Res 2008 1.06
40 Notch1 oncoprotein antagonizes TGF-beta/Smad-mediated cell growth suppression via sequestration of coactivator p300. Cancer Sci 2005 1.05
41 Crk-associated substrate lymphocyte type is required for lymphocyte trafficking and marginal zone B cell maintenance. J Immunol 2005 1.05
42 FDG-PET is effective in the detection of granulocytic sarcoma in patients with myeloid malignancy. Leuk Res 2010 1.05
43 Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2009 1.03
44 Loss of AML1/Runx1 accelerates the development of MLL-ENL leukemia through down-regulation of p19ARF. Blood 2011 1.01
45 Clinical features of late cytomegalovirus infection after hematopoietic stem cell transplantation. Int J Hematol 2008 1.01
46 Oligomerization of Evi-1 regulated by the PR domain contributes to recruitment of corepressor CtBP. Oncogene 2005 1.00
47 AML1 is functionally regulated through p300-mediated acetylation on specific lysine residues. J Biol Chem 2004 1.00
48 Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies. Cancer Sci 2009 1.00
49 The role of Runx1/AML1 and Evi-1 in the regulation of hematopoietic stem cells. J Cell Physiol 2010 0.99
50 Genomewide screening of DNA copy number changes in chronic myelogenous leukemia with the use of high-resolution array-based comparative genomic hybridization. Genes Chromosomes Cancer 2006 0.97
51 Essential roles of VLA-4 in the hematopoietic system. Int J Hematol 2010 0.96
52 Notch activation induces the generation of functional NK cells from human cord blood CD34-positive cells devoid of IL-15. J Immunol 2009 0.96
53 The IL-2/CD25 axis maintains distinct subsets of chronic myeloid leukemia-initiating cells. Blood 2014 0.96
54 Expression profiling of immature thymocytes revealed a novel homeobox gene that regulates double-negative thymocyte development. J Immunol 2007 0.96
55 Evi-1 as a critical regulator of leukemic cells. Int J Hematol 2010 0.94
56 Lymphomatoid granulomatosis involving central nervous system successfully treated with rituximab alone. Arch Neurol 2008 0.94
57 Leukemia-related transcription factor TEL is negatively regulated through extracellular signal-regulated kinase-induced phosphorylation. Mol Cell Biol 2004 0.94
58 Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation. Am J Hematol 2008 0.94
59 Homeoprotein DLX-1 interacts with Smad4 and blocks a signaling pathway from activin A in hematopoietic cells. Proc Natl Acad Sci U S A 2003 0.93
60 ESHAP therapy effective in a patient with Langerhans cell sarcoma. Int J Hematol 2008 0.93
61 Down-regulation of Runx1 expression by TCR signal involves an autoregulatory mechanism and contributes to IL-2 production. J Biol Chem 2011 0.93
62 The transcriptionally active form of AML1 is required for hematopoietic rescue of the AML1-deficient embryonic para-aortic splanchnopleural (P-Sp) region. Blood 2004 0.92
63 Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial. Int J Hematol 2011 0.92
64 Functional domains of Runx1 are differentially required for CD4 repression, TCRbeta expression, and CD4/8 double-negative to CD4/8 double-positive transition in thymocyte development. J Immunol 2005 0.92
65 Evi-1 promotes para-aortic splanchnopleural hematopoiesis through up-regulation of GATA-2 and repression of TGF-b signaling. Cancer Sci 2008 0.92
66 Temozolomide may induce therapy-related acute lymphoblastic leukaemia. Br J Haematol 2011 0.92
67 AML1/RUNX1 functions as a cytoplasmic attenuator of NF-κB signaling in the repression of myeloid tumors. Blood 2011 0.92
68 Structure and function of cas-L and integrin-mediated signaling. Crit Rev Immunol 2006 0.92
69 Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation. Int J Hematol 2011 0.92
70 Coordinated regulation of transcription factors through Notch2 is an important mediator of mast cell fate. Proc Natl Acad Sci U S A 2008 0.91
71 Early-onset therapy-related myelodysplastic syndrome originating from prolonged myelosuppression after fludarabine-based therapy. Intern Med 2012 0.90
72 Key roles of histone methyltransferase and demethylase in leukemogenesis. J Cell Biochem 2011 0.90
73 The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia. Exp Hematol 2007 0.89
74 The first case of blastic plasmacytoid dendritic cell neoplasm with MLL-ENL rearrangement. Leuk Res 2011 0.89
75 Runx1 deficiency in CD4+ T cells causes fatal autoimmune inflammatory lung disease due to spontaneous hyperactivation of cells. J Immunol 2012 0.89
76 T cell acute lymphoblastic leukemia arising from familial platelet disorder. Int J Hematol 2010 0.88
77 Blockade of class IB phosphoinositide-3 kinase ameliorates obesity-induced inflammation and insulin resistance. Proc Natl Acad Sci U S A 2011 0.88
78 Rapid diagnosis of invasive pulmonary aspergillosis by quantitative polymerase chain reaction using bronchial lavage fluid. Am J Hematol 2003 0.88
79 Treatment of primary intraocular lymphoma with rituximab, high dose methotrexate, procarbazine, and vincristine chemotherapy, reduced whole-brain radiotherapy, and local ocular therapy. Br J Haematol 2011 0.88
80 The effect of iron overload and chelation on erythroid differentiation. Int J Hematol 2011 0.87
81 CD1d expression level in tumor cells is an important determinant for anti-tumor immunity by natural killer T cells. Leuk Lymphoma 2006 0.87
82 Ecotropic viral integration site 1, stem cell self-renewal and leukemogenesis. Cancer Sci 2012 0.87
83 A case of Schizophyllum commune sinusitis following unrelated cord blood transplantation for acute lymphoblastic leukemia. Int J Hematol 2013 0.87
84 Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level. Am J Hematol 2008 0.86
85 Dual antitumor mechanisms of Notch signaling inhibitor in a T-cell acute lymphoblastic leukemia xenograft model. Cancer Sci 2009 0.86
86 Simultaneous appearance of central nervous system relapse and subarachnoid hemorrhage during the treatment for acute promyelocytic leukemia. Ann Hematol 2008 0.86
87 Intensive chemotherapy for elderly patients with acute myelogeneous leukemia: a propensity score analysis by the Japan Hematology and Oncology Clinical Study Group (J-HOCS). Ann Hematol 2012 0.86
88 Clinical significance of serum-soluble interleukin-2 receptor in patients with follicular lymphoma. Clin Lymphoma Myeloma Leuk 2013 0.86
89 Unique association of Waldenström macroglobulinemia with optic neuritis and monoclonal T cell expansion. Int J Hematol 2013 0.86
90 Thalidomide maintenance therapy for patients with multiple myeloma: meta-analysis. Leuk Res 2012 0.86
91 Early relapse of JAK2 V617F-positive chronic neutrophilic leukemia with central nervous system infiltration after unrelated bone marrow transplantation. Am J Hematol 2007 0.85
92 Pretransplant predictors and posttransplant sequels of acute kidney injury after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2010 0.85
93 Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation. Am J Hematol 2007 0.85
94 Beneficial and adverse effects of molecularly targeted therapies for acute promyelocytic leukemia in central nervous system. CNS Neurol Disord Drug Targets 2009 0.85
95 Allogeneic stem cell transplantation for adult Philadelphia chromosome-negative acute lymphocytic leukemia: comparable survival rates but different risk factors between related and unrelated transplantation in first complete remission. Blood 2010 0.85
96 False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation. J Antimicrob Chemother 2007 0.84
97 Evi1 forms a bridge between the epigenetic machinery and signaling pathways. Oncotarget 2011 0.84
98 Hyperbilirubinemia after hematopoietic stem cell transplantation: comparison of clinical and pathologic findings in 41 autopsied cases. Clin Transplant 2011 0.84
99 Fatal amebic colitis after high-dose dexamethasone therapy for newly diagnosed multiple myeloma. Ann Hematol 2010 0.84
100 Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes. J Med Virol 2008 0.84
101 Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients. J Antimicrob Chemother 2007 0.83
102 Inhibition of histone methyltransferase EZH2 depletes leukemia stem cell of mixed lineage leukemia fusion leukemia through upregulation of p16. Cancer Sci 2014 0.83
103 Immunotherapy against metastatic renal cell carcinoma with mature dendritic cells. Int J Urol 2007 0.83
104 Reversible posterior leukoencephalopathy syndrome following R-CHOP therapy for diffuse large B-cell lymphoma. Ann Hematol 2009 0.83
105 Mycosis fungoides with recurrent Hodgkin's lymphoma and diffuse large B-cell lymphoma. Acta Derm Venereol 2009 0.83
106 Reduced-intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first-donor origin. Am J Hematol 2003 0.83
107 Hyperlipidemia after allogeneic stem cell transplantation: prevalence, risk factors, and impact on prognosis. Clin Transplant 2012 0.83
108 Notch2 signaling is required for proper mast cell distribution and mucosal immunity in the intestine. Blood 2010 0.83
109 Recurrent pericardial effusion after treatment for primary effusion lymphoma-like lymphoma: an autopsied case. Ann Hematol 2010 0.82
110 Safety of high-dose micafungin for patients with hematological diseases. Leuk Lymphoma 2014 0.82
111 A prospective study of cyclosporine A treatment of patients with low-risk myelodysplastic syndrome: presence of CD55(-)CD59(-) blood cells predicts platelet response. Int J Hematol 2007 0.82
112 Hematopoietic stem cells expanded by fibroblast growth factor-1 are excellent targets for retrovirus-mediated gene delivery. Exp Hematol 2005 0.82
113 Blimp-1 is a tumor suppressor gene in lymphoid malignancies. Int J Hematol 2010 0.82
114 Multiple phosphorylation sites are important for RUNX1 activity in early hematopoiesis and T-cell differentiation. Eur J Immunol 2012 0.82
115 Haemophagocytic lymphohistiocytosis is a recurrent and specific complication of acute erythroid leukaemia. Br J Haematol 2011 0.82
116 Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells. Oncogene 2003 0.82
117 Successful hematopoietic stem cell transplantation from an HLA-identical sibling in a patient with aplastic anemia after HLA-haploidentical living-related liver transplantation for fulminant hepatitis. Biol Blood Marrow Transplant 2009 0.81
118 The shortest isoform of C/EBPβ, liver inhibitory protein (LIP), collaborates with Evi1 to induce AML in a mouse BMT model. Blood 2013 0.81
119 A case of adult Langerhans cell histiocytosis showing successfully regenerated osseous tissue of the skull after chemotherapy. Int J Hematol 2008 0.81
120 A case of myeloid sarcoma with correlation to JAK2V617F mutation, complicated by myelofibrosis and secondary acute myeloid leukemia. Intern Med 2011 0.81
121 Crk-associated substrate lymphocyte type regulates myeloid cell motility and suppresses the progression of leukemia induced by p210Bcr/Abl. Cancer Sci 2011 0.81
122 Early onset of acute lymphoblastic leukemia with MLL rearrangement after autologous stem cell transplantation for multiple myeloma. Ann Hematol 2009 0.81
123 p130Cas, Crk-associated substrate, plays important roles in osteoclastic bone resorption. J Bone Miner Res 2013 0.81
124 Biliary cast syndrome and benign biliary stricture as complications of allogeneic hematopoietic stem cell transplantation. Ann Hematol 2010 0.81
125 An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP). Int J Hematol 2012 0.80
126 Functional regulation of TEL by p38-induced phosphorylation. Biochem Biophys Res Commun 2002 0.80
127 Pharmacokinetics of ganciclovir in haematopoietic stem cell transplantation recipients with or without renal impairment. J Antimicrob Chemother 2006 0.80
128 Simultaneous increase in 1,3-β-D-glucan and procalcitonin levels in Pseudomonas aeruginosa infection. J Infect 2013 0.80
129 A novel MLL-AF1p/Eps15 fusion variant in therapy-related acute lymphoblastic leukemia, lacking the EH-domains. Leuk Res 2009 0.80
130 Successful management of Rothia aeria pneumonia during the peritransplant period: first reported case in allogeneic hematopoietic stem cell transplant. Leuk Lymphoma 2014 0.80
131 Complete molecular remission in refractory acute myeloid leukemia with MLL/AF9 treated with gemtuzumab ozogamicin. Leuk Res 2010 0.80
132 Conventional allogeneic hematopoietic stem cell transplantation for lymphoma may overcome the poor prognosis associated with a positive FDG-PET scan before transplantation. Am J Hematol 2008 0.80
133 The significance of free light chain measurements in the diagnosis of myelomatous pleural effusion. Ann Hematol 2014 0.79
134 The effect of decreased-dose idarubicin for elderly patients with acute myeloid leukemia. Jpn J Clin Oncol 2013 0.79
135 Risk-adapted maintenance therapy for acute promyelocytic leukemia. J Clin Oncol 2009 0.79
136 Intracellular reactive oxygen species mark and influence the megakaryocyte-erythrocyte progenitor fate of common myeloid progenitors. Stem Cells 2014 0.79
137 AL amyloidosis with severe gastrointestinal invasion and acute obstructive suppurative cholangitis. Ann Hematol 2011 0.79
138 Ischemic colitis as a manifestation of thrombotic microangiopathy following bone marrow transplantation. Intern Med 2003 0.79
139 Generation of iPS cells from normal and malignant hematopoietic cells. Int J Hematol 2013 0.79
140 The race and dose of chemotherapy should be considered for optimizing maintenance therapy for acute promyelocytic leukemia. Leuk Res 2009 0.79
141 An indeterminate result of QuantiFERON-TB Gold In-Tube for miliary tuberculosis due to a high level of IFN-γ production. Int J Hematol 2014 0.78
142 A case of CD20-positive peripheral T-cell lymphoma treated with rituximab and multiagent chemotherapy. Int J Dermatol 2013 0.78
143 Acute eosinophilic pneumonia is a non-infectious lung complication after allogeneic hematopoietic stem cell transplantation. Int J Hematol 2009 0.78
144 Roles of AML1/RUNX1 in T-cell malignancy induced by loss of p53. Cancer Sci 2013 0.78
145 Disseminated adenovirus disease by multiple adenovirus serotypes following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2008 0.78
146 Clinical significance of detection of immature platelets: comparison between percentage of reticulated platelets as detected by flow cytometry and immature platelet fraction as detected by automated measurement. Eur J Haematol 2009 0.78
147 Molecular or cytogenetic monitoring and preemptive therapy for central nervous system relapse of acute promyelocytic leukemia. Haematologica 2010 0.78
148 [Frequent inactivation of A20 through gene mutation in B-cell lymphomas]. Rinsho Ketsueki 2011 0.78
149 The negative impact of female donor/male recipient combination in allogeneic hematopoietic stem cell transplantation depends on disease risk. Transpl Int 2011 0.78
150 Durable remission after the administration of rituximab for EBV-negative, diffuse large B-cell lymphoma following autologous peripheral blood stem cell transplantation for angioimmunoblastic T-cell lymphoma. Leuk Lymphoma 2007 0.78
151 AML1 enhances the expression of leukotriene B4 type-1 receptor in leukocytes. FASEB J 2010 0.78
152 Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab. Am J Hematol 2008 0.78
153 Expression and tyrosine phosphorylation of Crk-associated substrate lymphocyte type (Cas-L) protein in human neutrophils. J Cell Biochem 2008 0.78
154 An orphan PRD class homeobox gene expressed in mouse brain and limb development. Dev Genes Evol 2002 0.78
155 Splenic peliosis in a patient with aplastic anemia during danazol therapy. Int J Hematol 2007 0.78
156 A myeloablative conditioning regimen for patients with impaired cardiac function undergoing allogeneic stem cell transplantation: reduced cyclophosphamide combined with etoposide and total body irradiation. Am J Hematol 2008 0.78
157 Herpes simplex encephalitis and subsequent cytomegalovirus encephalitis after chemoradiotherapy for central nervous system lymphoma: a case report and literature review. Int J Hematol 2008 0.78
158 Clinical significance of peripheral blood erythroblastosis after hematopoietic stem cell transplantation. Leuk Lymphoma 2004 0.78
159 Nilotinib-induced hypothyroidism in a patient with chronic myeloid leukemia. Int J Hematol 2011 0.78
160 Comparison between pulsed high-dose dexamethasone and daily corticosteroid therapy for adult primary immune thrombocytopenia: a retrospective study. Intern Med 2012 0.77
161 A comparative analysis of meropenem and doripenem in febrile patients with hematologic malignancies: a single-center retrospective study. Jpn J Infect Dis 2012 0.77
162 Folliculotropic mycosis fungoides with severe hepatic failure due to hepatic involvement. Acta Derm Venereol 2009 0.77
163 The impact of molecularly targeted therapies upon the understanding of leukemogenesis and the role of hematopoietic stem cell transplantation in acute promyelocytic leukemia. Curr Stem Cell Res Ther 2010 0.77
164 Identification of a SRC-like tyrosine kinase gene, FRK, fused with ETV6 in a patient with acute myelogenous leukemia carrying a t(6;12)(q21;p13) translocation. Genes Chromosomes Cancer 2005 0.77
165 Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease. J Am Acad Dermatol 2007 0.77
166 Primary MALT lymphoma of the urinary bladder in the background of interstitial cystitis. Ann Hematol 2012 0.77
167 Jumping translocation involving 1q21 during long-term complete remission of acute myeloid leukemia. Ann Hematol 2009 0.77
168 A case of anaplastic large cell lymphoma, ALK positive, primary presented in the skin and relapsed with systemic involvement and leukocytosis after years of follow-up period. Int J Hematol 2010 0.77
169 A new three-way variant t(15;22;17)(q22;q11.2;q21) in acute promyelocytic leukemia. Int J Hematol 2009 0.77
170 Concurrent development of "Burkitt-like" lymphoma and BCL-2-rearranged low-grade B cell lymphoma sharing the same germinal center origin. Int J Hematol 2010 0.77
171 Clinical evaluation of WT1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes. Leuk Lymphoma 2012 0.77
172 Generation of transgenic mice on an NOD/SCID background using the conventional microinjection technique. Biol Reprod 2010 0.77
173 Successful Control of Carcinoma of Unknown Primary with Axitinib, a Novel Molecular-Targeted Agent: A Case Report. Chemotherapy 2015 0.77
174 Progressive transition of Epstein-Barr virus associated lymphoproliferative disease subtypes with the development of lung cancer. Am J Hematol 2009 0.77
175 Fulminant myocarditis after allogeneic bone marrow transplantation: successful cytomegalovirus therapy and mechanical circulatory support for bridge to recovery. Biol Blood Marrow Transplant 2009 0.77
176 Pituitary lymphoma developing within pituitary adenoma. Int J Hematol 2012 0.76
177 Long-term sustained mixed chimerism after allogeneic stem cell transplantation in a patient with severe aplastic anemia. Intern Med 2007 0.76
178 Autotaxin enzyme immunoassay in human cerebrospinal fluid samples. Clin Chim Acta 2009 0.76
179 In vivo T-cell depletion with alemtuzumab in allogeneic hematopoietic stem cell transplantation: Combined results of two studies on aplastic anemia and HLA-mismatched haploidentical transplantation. Am J Hematol 2013 0.76
180 Erythroleukemia showing early erythroid and cytogenetic responses to azacitidine therapy. Ann Hematol 2012 0.76
181 A case report of non-traumatic renal artery pseudoaneurysm due to chemotherapy for diffuse large B-cell lymphoma. Ann Hematol 2009 0.76
182 Arsenic-induced pericardial and pleural effusion without acute promyelocytic leukemia differentiation syndrome. Leuk Res 2009 0.76
183 Development of hairy cell leukemia in familial platelet disorder with predisposition to acute myeloid leukemia. Platelets 2013 0.75
184 Eleven secondary cancers after hematopoietic stem cell transplantation using a total body irradiation-based regimen in 370 consecutive pediatric and adult patients. Springerplus 2013 0.75
185 Corrigendum: Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults. Nat Genet 2016 0.75
186 The t(3;21) fusion product, AML1/Evi-1 blocks AML1-induced transactivation by recruiting CtBP. Oncogene 2002 0.75
187 HIV-associated Burkitt lymphoma in a Japanese patient with early submandibular swelling. BMC Res Notes 2013 0.75
188 Drug-induced hypersensitivity syndrome with rapid hematopoietic reconstitution during treatment for acute myeloid leukemia. Haematologica 2008 0.75
189 Acute myeloid leukemia with cryptic CBFB-MYH11 type D. Int J Clin Exp Pathol 2012 0.75
190 How should we prevent hematologic relapse of acute promyelocytic leukemia? J Clin Oncol 2009 0.75
191 Comparison of temporal changes in psychological distress after hematopoietic stem cell transplantation among the underlying diseases of Japanese adult patients. Biopsychosoc Med 2008 0.75
192 Pharmacokinetics of alemtuzumab after haploidentical HLA-mismatched hematopoietic stem cell transplantation using in vivo alemtuzumab with or without CD52-positive malignancies. Am J Hematol 2006 0.75
193 High-dose dexamethasone therapy for severe thrombocytopenia and neutropenia induced by EBV infectious mononucleosis. Int J Hematol 2010 0.75
194 Successful treatment with recombinant thrombomodulin for B-cell lymphoma-associated hemophagocytic syndrome complicated by disseminated intravascular coagulation. Int J Clin Exp Pathol 2013 0.75
195 The criteria to suspect chronic myeloid leukemia using absolute basophil counts in peripheral blood. Int J Hematol 2015 0.75
196 Umbilical Cord Blood Transplantation-associated Nephrotic Syndrome Successfully Treated by Low-density Lipoprotein Apheresis. Intern Med 2016 0.75
197 [Difference in measurements of erythrocyte sedimentation rate obtained using two devices of the same model in a patient with marked leukocytosis]. Rinsho Byori 2014 0.75
198 Paraneoplastic pemphigus occurring after bendamustine and rituximab therapy for relapsed follicular lymphoma. Ann Hematol 2014 0.75
199 Lymphoma with specific affinity to endocrine organs. Ann Hematol 2011 0.75
200 Usefulness of double-balloon enteroscopy for evaluation of duodenal follicular lymphoma. Ann Hematol 2012 0.75
201 [Drug-induced thrombocytopenia]. Nihon Rinsho 2007 0.75
202 Modified ESHAP regimen for relapsed/refractory T cell lymphoma: a retrospective analysis. Ann Hematol 2015 0.75
203 Multicenter prospective trial evaluating the tolerability of imatinib for Japanese patients with chronic myelogenous leukemia in the chronic phase: does body weight matter? Am J Hematol 2008 0.75
204 Hepatocellular carcinoma in cirrhotic liver with graft-versus-host disease. Ann Hematol 2012 0.75
205 [Bone marrow failure syndrome (idiopathic hematopoietic disorders): progress in diagnosis and treatment. Topics: III. Diagnosis and treatments; 3. Myelodysplastic syndrome]. Nihon Naika Gakkai Zasshi 2012 0.75
206 Evaluation of procalcitonin with liquid-phase binding assay in hematological malignancy. Clin Chim Acta 2012 0.75
207 Favorable outcomes of tacrolimus compared with cyclosporine A for GVHD prophylaxis in HSCT for standard-risk hematological diseases. Ann Hematol 2014 0.75
208 Primary Retroperitoneal Tumor with Unexpected Gingival Involvement. Intern Med 2015 0.75
209 Primary gastrointestinal follicular lymphoma with histological transformation. Ann Hematol 2012 0.75
210 Prediction model for CD34 positive cell yield in peripheral blood stem cell collection on the fourth day after G-CSF administration in healthy donors. Int J Hematol 2013 0.75
211 Erdheim-Chester disease with an 18F-fluorodeoxyglucose-avid breast mass and BRAF V600E mutation. Jpn J Radiol 2014 0.75
212 [Development of molecular targeted therapy for hematological disorder in the era of genomic drug discovery]. Nihon Rinsho 2014 0.75
213 Distribution of serum erythropoietin levels in lower risk myelodysplastic syndrome cases with anemia. Int J Hematol 2013 0.75
214 Postremission gemtuzumab ozogamicin for elderly patients with acute myelogenous leukemia with favorable characteristics and comorbid conditions. Int J Hematol 2010 0.75
215 Fludarabine may overcome resistance to rituximab in IgM-related neuropathy. J Neurol Sci 2012 0.75
216 Chronic myelomonocytic leukemia presenting severe uterine hemorrhage due to uterine infiltration of leukemic cells and early-stage endometrial adenocarcinoma. Arch Gynecol Obstet 2009 0.75
217 Composite diffuse large B-cell lymphoma and CD20-positive peripheral T-cell lymphoma. Pathol Int 2011 0.75
218 Gene expression profiles of central nervous system lymphoma predict poor survival in patients with diffuse large B-cell lymphoma. Br J Haematol 2014 0.75
219 [Survey on examinations for diagnosis of bone marrow failure in Japan: a report from the Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes]. Rinsho Ketsueki 2012 0.75
220 A mixed-type autoimmune hemolytic anemia with immune thrombocytopenia related with myositis and post-transplantation lymphoproliferative disorder. Ann Hematol 2013 0.75
221 [Hematological diseases and induced pluripotent stem (iPS) cells]. Rinsho Ketsueki 2012 0.75
222 Pure red cell aplasia with follicular lymphoma showing regression and progression parallel to lymphoma. Int J Hematol 2011 0.75
223 A novel scoring system to predict the incidence of invasive fungal disease in salvage chemotherapies for malignant lymphoma. Ann Hematol 2014 0.75
224 Intravascular large B-cell lymphoma with symptoms resembling progressive dementia: a clinical case report. J Am Geriatr Soc 2013 0.75
225 Human invariant natural killer T cells: implications for immunotherapy. Int J Hematol 2009 0.75
226 [Pathogenetic significance of deregulated hematopoietic transcription factors in leukemia--Evi-1 as a critical regulator for hematopoiesis and leukemia]. Rinsho Ketsueki 2009 0.75
227 [Induced pluripotent stem cells from leukemia patients as a platform for dissecting pathogenesis]. Rinsho Ketsueki 2014 0.75
228 [Acute myeloid leukemia]. Nihon Rinsho 2012 0.75
229 Evidence for basophilic differentiation of acute promyelocytic leukaemia cells during arsenic trioxide therapy. Br J Haematol 2008 0.75
230 Role of procalcitonin and C-reactive protein for discrimination between tumor fever and infection in patients with hematological diseases. Leuk Lymphoma 2014 0.75
231 [Basic science and pathophysiology of MDS: from a view of its neoplastic aspect and the molecular basis]. Rinsho Ketsueki 2013 0.75
232 Hemoperitoneum due to spontaneous rupture of the left gastroepiploic artery in a patient with hemophilia A. Ann Hematol 2008 0.75
233 How Should We Treat Early Post-Transplant Lymphoproliferative Disease After Heart Transplantation? Int Heart J 2015 0.75
234 Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase: results from the Japanese subgroup of ENESTnd. Int J Hematol 2011 0.75
235 Follicular lymphoma presenting with massive splenomegaly. Int J Hematol 2011 0.75
236 [Leukemia stem cell and clonal evolution]. Nihon Rinsho 2014 0.75
237 The role of alloantibodies against human platelet antigen-15 in multiply platelet transfused patients. Transfusion 2013 0.75
238 [Diagnosis and therapy for multiple myeloma: Practice guidelines]. Nihon Naika Gakkai Zasshi 2007 0.75
239 Primary cutaneous anaplastic large cell lymphoma with leg involvement: a case report and review of 11 cases. J Dermatol 2011 0.75
240 Successful allogeneic stem cell transplantation for Lennert lymphoma. Ann Hematol 2012 0.75
241 Effective azacitidine treatment for myelodysplastic syndrome transformed from essential thrombocythemia. Rinsho Ketsueki 2013 0.75
242 IgG-associated immune thrombocytopenia in Waldenström macroglobulinemia. Int J Hematol 2010 0.75
243 [Molecular pathogenesis of leukemias]. Rinsho Ketsueki 2009 0.75
244 Heparin-mediated inhibition of PCR in the accelerated phase of chronic myeloid leukaemia characterised by abundant basophilia. Eur J Haematol 2014 0.75
245 Efficacy of pleural biopsy for diagnosis of pleural effusion due to chronic GVHD after hematopoietic stem cell transplantation. Int J Hematol 2012 0.75
246 Effect of graft sources on allogeneic hematopoietic stem cell transplantation outcome in adults with chronic myeloid leukemia in the era of tyrosine kinase inhibitors: a Japanese Society of Hematopoietic Cell Transplantation retrospective analysis. Int J Hematol 2014 0.75
247 Mutational analyses of the AML1 gene in patients with myelodysplastic syndrome. Leuk Lymphoma 2002 0.75
248 Idiopathic dysplasia of undetermined/uncertain significance (IDUS) initially presenting erythroblastosis and hyperferritinemia. Rinsho Ketsueki 2015 0.75
249 [The pathogenetic significance of deregulated hematopoietic transcription factors in leukemia]. Rinsho Ketsueki 2007 0.75
250 [Genetic and cytogenetic abnormalities in leukemia]. Nihon Rinsho 2012 0.75
251 Simple but powerful prognostic scoring model for MALT lymphoma: a retrospective study. Ann Hematol 2012 0.75
252 Rituximab therapy for refractory immune thrombocytopenic purpura in elder patients. Int J Hematol 2010 0.75
253 Hemorrhagic cystitis in a patient receiving gemtuzumab ozogamicin for relapsed acute promyelocytic leukemia after cord blood transplantation. Ann Hematol 2008 0.75
254 Elevated serum levels of soluble interleukin-2 receptor in chronic eosinophilic leukemia/hypereosinophilic syndrome with FIP1L1-PDGFR alpha fusion gene. Int J Hematol 2008 0.75
255 Interstitial pneumonia associated with progression of myelodysplastic syndrome. Int J Hematol 2009 0.75
256 Molecular and cytogenetic response of chronic myelogenous leukemia treated with imatinib mesylate: one institutional experience in Japan. Int J Hematol 2008 0.75
257 CD30-positive anaplastic variant diffuse large B cell lymphoma: a rare case presented with cutaneous involvement. Int J Hematol 2010 0.75
258 Evans syndrome with cytomegalovirus infection followed by emerging peripheral T-cell lymphoma. Ann Hematol 2011 0.75
259 Pulmonary lymphocyte-rich classical Hodgkin lymphoma with early response to ABVD therapy. Ann Hematol 2013 0.75
260 [Bone and Stem Cells. The next frontier in allogeneic hematopoietic stem cell transplantation]. Clin Calcium 2014 0.75
261 Late-onset pneumatosis cystoides intestinalis associated with non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation. Int J Hematol 2008 0.75
262 [The shortest isoform of C/EBPβ, Liver inhibitory protein (LIP), collaborates with Evi1 to induce AML in a mouse BMT model]. Rinsho Ketsueki 2013 0.75
263 Single-cell gene expression analysis reveals clonal architecture of blast-phase chronic myeloid leukaemia. Br J Haematol 2014 0.75
264 Successful treatment of secondary NK/T-cell lymphoma of the testis. Ann Hematol 2012 0.75
265 Simultaneous appearance of methotrexate-associated lymphoproliferative disorder and tuberculous meningitis demonstrating the definitive role of immunosuppression. Ann Hematol 2008 0.75
266 [Molecular mechanisms in the development of acute myeloid leukemia]. Nihon Rinsho 2009 0.75
267 MALT lymphoma of the small bowel with protein-losing enteropathy. Int J Hematol 2014 0.75
268 Treatment results of chemoradiation therapy for localized aggressive lymphomas: A retrospective 20-year study. Ann Hematol 2006 0.75